Sickle cell patients to have quicker and more accessible treatment in England
People living with sickle cell disease in England are to benefit from quicker and more accessible treatment due to a £9m investment, the government has announced.
Apheresis services, which are a type of treatment that removes harmful components from a patient's blood, are to improve across England through the funding of more specialist treatment centres. The funding will ensure the wider availability of machines that remove a patient's sickled red blood cells and replace them with healthy donor cells.
More than 20 NHS trusts currently offer Spectra Optia technology, a treatment more effective than blood transfusions and having been shown to be highly effective in reducing complications such as iron overload.
The investment could save the NHS up to £12.9m every year thanks to a reduction in time spent in hospital for patients and the reduced need for other treatments, according to the government.
Sickle cell disease primarily affects people from an African-Caribbean background. In England, about 17,000 people are living with the disease, an inherited blood disorder, with 250 new cases a year.
Wes Streeting, the health and social care secretary, said: 'People living with rare conditions like sickle cell disease face immense everyday challenges, and can sometimes struggle to get the specialised care they need.
'To make our health service fit for the future, we have to harness the power of new technologies, and these machines provide a shining example of how our government is starting to make huge advancements in digital healthcare.
'Through our plan for change, this government will be the one that removes the barriers to getting the latest and best tech to our NHS frontline, so patients can access the best care available, closer to home.'
Prof Bola Owolabi, the director of healthcare inequalities at NHS England, said: 'This is great news for people living with sickle cell disease – a condition that disproportionately affects Black African and Black Caribbean communities.
'Sickle cell patients have needed new treatment options for decades and this additional funding will provide greater access to this life-changing technology which has the potential to significantly improve patients' quality of life.'
Owolabi added that sickle cell care in England continued to be among the best in the world, with England the first country to introduce a groundbreaking gene-editing therapy, which offers a functional cure to the disease.
Sign up to First Edition
Our morning email breaks down the key stories of the day, telling you what's happening and why it matters
after newsletter promotion
'Alongside this important step, the recent approval of a new gene-editing therapy for patients with severe sickle cell disease showcases the NHS's clear commitment to improving outcomes for the 17,000 people living with the condition in England,' Owolabi said.
John James, the chief executive of the Sickle Cell Society, said: 'We are delighted to see the arrival of this long-overdue funding, which will improve access to vital treatment for people living with sickle cell disorder and their families.
'This announcement follows years of collaboration between the Sickle Cell Society and the NHS, and we're pleased that this investment will help make access to care fairer, more consistent, and far less stressful for many individuals.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
44 minutes ago
- Daily Mail
Scientists pinpoint way to check if you're going to get early-onset colon cancer with up to 92% accuracy
A little-known at-home test can detect early-onset colon cancer before symptoms develop, increasing the chance of surviving a disease that is surging among young people. The fecal immunochemical test (FIT) costs $49 and screens a person's feces for flecks of blood, a warning sign of the cancer — as tumors cause bleeding. The test is FDA-approved and allows younger people a chance to screen for colon cancer before they reach the recommended age for a colonoscopy, 45 years. If blood is detected, a colonoscopy is performed, increasing the chances of catching colon cancer early when it is more treatable. And the American College of Surgeons says it is generally accurate, able to detect about 80 percent of all cases. If someone opts for the $600 FIT with DNA screening, which checks for abnormal changes in cells' DNA, accuracy rises to 92 percent. A colonoscopy is about 99 percent accurate at detecting all cancers. A recent study found people that use the FIT method between the ages of 40 to 49 years old are 39 percent less likely to die from colon cancer than their peers who wait to get the test until they are 50 years old or above. An increasing number of younger people are seeking screening, as the US experiences a surge in colon cancer among people under 50, with young patients today about twice as likely to be diagnosed with the disease than their grandparents. The rising rates are prompting some physicians to urge Americans to start getting screened for the disease before the age of 45 years, which is when US doctors recommend. For the test, which can be ordered online, customers are sent a package containing a collection tube. They are asked to collect a sample of their feces from the toilet bowl, place it in the tube and mail it to a lab. Results take about five days to come back. In the lab, scientists expose the feces to antibodies that can bind to human hemoglobin - a protein found in red blood cells. If they bind to an area of the feces, a positive test result is issued - and patients are advised to undertake further screening. In the FIT with DNA, scientists also analyze cells found in the stool for abnormal changes - which could indicate cancer. Patients over 45 years old who have an average risk — meaning no family history of the disease — may be recommended the test, which is free for the group under health insurance plans. But people can also buy the test, which is sold by labs like Everlywell for $49, or opt for other tests like Cologuard, which is priced at $121. While the test can be extremely helpful, doctors caution that about five to 10 percent of patients who get a positive result do not have colon cancer or advanced polyps. The number of false positives after a colonoscopy is below one percent. It is important to follow up with a doctor to discuss results. Patients undertaking the test are recommended to do it every year, as this can help to catch early-onset cancers which are typically slower growing. Among patients to have their cancer caught after using an at-home stool-based test is Christine Bronstein, who was diagnosed with the cancer at age 48. The Hawaii local exercises regularly, and avoids sugar and alcohol. But after seeing blood in her stool in 2021, she became concerned and ordered a stool-based test. After results came back positive, she rushed to see her doctor and was eventually approved for a colonoscopy - which led to a stage three colon cancer diagnosis with a two-inch tumor found in her rectum. Bronstein told TODAY: 'I'm very lucky that I did my test when I did. This thing really takes people down right in their prime... I think the problem why this is becoming the No.1 killer for younger people is because their symptoms get denied.' Colon cancer cases are surging among under-50s in the US in an uptick that has stunned researchers, with adults born in the 1980s having double the risk of suffering from the cancer compared to their parents. Among adults aged 25 to 29 years, colon cancer cancer rates have spiked 85 percent in two decades according to CDC data. At the same time, over the last 30 years cases have dropped among over-50s by 30 percent.
The Sun
an hour ago
- The Sun
Aldi selling bargain £1.69 Kombucha in a bottle with three new flavours and they're perfect for summer
ALDI has launched a new range of drinks that are tasty, good for your gut, and affordable. The retailer's new range of Kombucha is available for just £1.69 a bottle. Launching earlier this week, the drinks are available in a range of refreshing flavours. The Juice Company Kombucha 330ml is available in passionfruit, ginger & lemon and wild berry. With Kombucha growing in popularity in recent years over claims that it boosts your gut health, the retailer decided to launch their own version after they noticed a 35% increase in searches on their website. Google searches for Kombucha have also seen a spike, with statistics showing a 26% increase in searches over the last year. Containing live cultures, the low sugar, lightly sparkling drink is the perfect beverage to cool off on a hot summer's day - all while looking after your wellbeing. Aldi described their passionfruit kombucha as "bursting with a sweet yet tart flavour" as it "combin[es] a tropical tang with bubbly refreshment." For those looking for a "kick of citrus" that provides a "warming immune system boost", the Ginger and Lemon Kombucha might be a good option. Finally, the Wild Berry flavour "brings a symphony of delicious berries." At just £1.69 a bottle it's the perfect time to stock up on all of the flavours of the refreshing cold drink. With its vibrant packaging, the drinks are sure to stand out on Aldi's shelves after it became available in store on June 11. How do get the perfect summer glow up with Aldi's latest middle aisle beauty buys including a £4.99 serum that'll revitalise dull skin AND smells amazing The product is part of Aldi's wider range of gut-health boosting items. This includes their new Kefir Frozen Yoghurt which is available for just £2.29. It is packed full of calcium and protein to boost your gut health, and is available in a delicious range of flavours including chocolate, mango & passionfruit and strawberry. Kefir is a cultured, fermented milk drink that can help support your immune system thanks to its probiotic bacteria. Studies suggest that the nutrient-dense dairy product might protect against bacterial infection as well as potentially reducing blood pressure and the risk of heart disease. For a more traditional form of Kefir, shoppers can find a Kefir drink, and Kefir yogurts at the affordable retailer. With their Kefir yoghurt available in natural, strawberry or mango flavours for £1.09 per 350g pot, it's easier than ever to look after your wellbeing. Aldi is offering an affordable range of wellbeing-focused products, with a comparable Yeo Valley yogurt retailing at Tesco for £2. Its 750ml Kefir drink is also available in a natural or mixed berry flavour and retails for just £2.09. All of these great, gut-focused products are ready to buy in store, subject to availability. 4
The Guardian
2 hours ago
- The Guardian
MPs back bill changes to prevent medics raising assisted dying with under-18s
Medics would not be allowed to raise assisted dying as an option with under-18s, and advertising it would be banned under changes backed by MPs on Friday before a final vote expected next week. The Commons voted on amendments to the assisted dying bill, which would legalise the option for terminally ill adults in England and Wales who have been told they have fewer than six months to live. The final Commons vote is scheduled on 20 June, with support and opposition finely balanced – and growing scrutiny over timelines, loopholes and who would ultimately deliver the system. A majority of MPs approved a clause tabled by Labour MP Meg Hillier, an opponent of the bill, to ensure health professionals cannot raise the topic of assisted dying with under-18s. A separate amendment from Hillier to bar health workers from bringing up assisted dying with adult patients before they have raised it themselves was voted down. There were impassioned interventions from both sides of the debate. Rupa Huq, the Labour MP for Ealing Central, said the cost-of-living crisis would make assisted dying 'quite attractive' to people who were struggling. 'We know that BAME communities have lower disposable household income than standard households, and you can just imagine relatives in a housing crisis wanting to speed up grandad's probate to get a foot on the ladder, or granny or nanny, ma or daddy even convincing themselves that, 'look, they'd be better off out of the way given the cost of care,'' Huq said. Caroline Voaden, the Liberal Democrat MP for South Devon, recalled the death of her husband, who she said had been 'in extreme pain' with terminal oesophageal cancer, and urged her colleagues to 'mind our language' after words like 'murder' were used. 'This is about helping people die in a civilised way and helping their families not go through a horrendous experience of watching a loved one die in agony,' Voaden said. MPs voted in favour of a proposal by Kim Leadbeater, who is sponsoring the bill, to ban advertisements about assisted dying. But they rejected a separate proposal from Labour MP Paul Waugh for tighter regulations which would have limited exceptions on Friday's amendments. Waugh said he hoped that 'enough MPs now realise that it is not fit for purpose'. The bill passed its first stage by a majority of 55 in November. Since then more than a dozen are thought to have switched sides to oppose the bill, though at least three have moved to support it. A number of other amendments were passed on Friday, including a provision for assisted dying deaths to not automatically be referred to a coroner and an attempt to regulate substances for use in assisted dying. Demonstrators for and against a change in the law gathered outside parliament to make their views known. Sign up to Headlines UK Get the day's headlines and highlights emailed direct to you every morning after newsletter promotion Opening the debate, Leadbeater said it was not about a choice between assisted dying or palliative care. 'Palliative and end-of-life care and assisted dying can and do work side by side to give terminally-ill patients the care and choice they deserve in their final days,' she said. As it stands, the proposed legislation would allow terminally-ill adults in England and Wales, with fewer than six months to live, to apply for an assisted death, subject to approval by two doctors and a panel featuring a social worker, senior legal figure and psychiatrist. MPs are entitled to have a free vote on the bill and any amendments, meaning they vote according to their conscience rather than along party lines. The government is neutral on the legislation. Stephen Kinnock, a health minister, said there had been more than 90 hours of parliamentary time spent debating the proposals so far, and more than 500 amendments had been considered at committee stage earlier this year.
